Skip to main content

Together we are beating cancer

Donate now

Sophie Wedekind

Sophie studied Biomedical Science at the University of Warwick before going on to complete a Master’s in Nutrition at King’s College London. After graduating, she worked for Imperial College London as a research technician in the department of Surgery and Cancer. She joined the digital news team at Cancer Research UK in December 2022, writing for Cancer News and producing our podcast, That Cancer Conversation.
Showing 12 out of 28 results
Two researchers chatting in the lab

The Lung Cancer Centre of Excellence (LCCE) in Manchester and London will continue their groundbreaking research with up to £4m of funding support from ScottishPower.  The Lung Cancer Centre of Excellence (LCCE) in Manchester and London will continue their groundbreaking research with up to £4m of funding support from ScottishPower. 

by Sophie Wedekind | News | 20 November 2024

20 November 2024

Grapes

Scientists, funded by Cancer Research UK, are finding out if an ingredient commonly found in red grapes could hold the answer to help prevent bowel cancer. Scientists, funded by Cancer Research UK, are finding out if an ingredient commonly found in red grapes could hold the answer to help prevent bowel cancer.

by Sophie Wedekind | News | 11 November 2024

11 November 2024

purple stained multiple myeloma cells

The National Institute for Health and Care Excellence (NICE) has recommended the use of elranatamab for adults with multiple myeloma, a cancer that forms in a type of white blood cell called a plasma cell. The National Institute for Health and Care Excellence (NICE) has recommended the use of elranatamab for adults with multiple myeloma, a cancer that forms in a type of white blood cell called a plasma cell.

by Sophie Wedekind | News | 1 November 2024

1 November 2024

Brain scans

A pioneering UK-wide trial, the 5G trial, has been awarded over £3m, by Cancer Research UK and the Minderoo Foundation, to test new treatments for people living with brain cancer.   A pioneering UK-wide trial, the 5G trial, has been awarded over £3m, by Cancer Research UK and the Minderoo Foundation, to test new treatments for people living with brain cancer.  

by Sophie Wedekind | News | 23 October 2024

23 October 2024

3D image of blood vessels in the hand, taken using a photoacoustic tomography scanner.

A new scanner, that has been developed by University College London (UCL) researchers, is able to generate highly detailed 3D images in seconds. Using this technology could offer the potential for earlier disease diagnosis in a clinical setting for the first time. A new scanner, that has been developed by University College London (UCL) researchers, is able to generate highly detailed 3D images in seconds. Using this technology could offer the potential for earlier disease diagnosis in a clinical setting for the first time.

by Sophie Wedekind | News | 15 October 2024

15 October 2024

A magnified image of squamous cell carcinoma, the most common type of cervical cancer.

Researchers funded by Cancer Research UK have made the biggest improvement in cervical cancer treatment in more than 20 years by changing how we use existing drugs.  Researchers funded by Cancer Research UK have made the biggest improvement in cervical cancer treatment in more than 20 years by changing how we use existing drugs. 

by Sophie Wedekind | 14 October 2024

14 October 2024

vaccine vials on a production line with a gloved hand reaching to grab one of them

Researchers at the University of Oxford have been awarded up to £600,000 from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer. Researchers at the University of Oxford have been awarded up to £600,000 from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer.

by Sophie Wedekind | News | 4 October 2024

4 October 2024

A couple holding hands in a doctor's waiting room

Our latest analysis suggests there could be more than 900,000 cancer deaths in the UK by the end of the new government’s first parliamentary term if we don't take bold action. Our latest analysis suggests there could be more than 900,000 cancer deaths in the UK by the end of the new government’s first parliamentary term if we don't take bold action.

by Sophie Wedekind | Analysis | 9 September 2024

9 September 2024

scientists in a lab

Cancer Research UK and LifeArc are investing £28m in funding and resources as part of a pioneering international initiative dedicated to developing new medicines exclusively for children’s and young people’s cancers. Cancer Research UK and LifeArc are investing £28m in funding and resources as part of a pioneering international initiative dedicated to developing new medicines exclusively for children’s and young people’s cancers.

by Sophie Wedekind | News | 5 September 2024

5 September 2024

stained microscopic sample of stomach cancer cells

The immunotherapy drug pembrolizumab (also known as Keytruda) has been approved as an option for people with advanced gastric cancer. The immunotherapy drug pembrolizumab (also known as Keytruda) has been approved as an option for people with advanced gastric cancer.

by Sophie Wedekind | News | 7 August 2024

7 August 2024